Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Patrik Šulc"'
Autor:
Jiří Plášek, Jozef Dodulík, Marie Lazárová, David Stejskal, Zdeněk Švagera, Nela Chobolová, Patrik Šulc, Lukáš Evin, Dana Purová, Jan Václavík
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Externí odkaz:
https://doaj.org/article/41cff616fe2a4af4bc4c0140f5111329
Autor:
Jiří Plášek, Jozef Dodulík, Marie Lazárová, David Stejskal, Zdeněk Švagera, Nela Chobolová, Patrik Šulc, Lukáš Evin, Dana Purová, Jan Václavík
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2024)
BackgroundSecretoneurin (SN) is a neuropeptide with potential utility as a biomarker of cardiovascular episodes. The main effect of SN is mediated through its inhibition of calmodulin-dependent kinase II (CaMKII), which influences calcium handling. W
Externí odkaz:
https://doaj.org/article/ebb2084a266d449ea66ebac0596cc0fe
Publikováno v:
Vnitřní lékařství. 68:154-158
Chronic heart failure (HF), like any chronic disease, is a medical and socioeconomic burden. The number of patients with HF is increasing and our effort is to apply the most effective way of care in practice, preferably together with using telemedici
Autor:
Jiří Plášek, Marie Lazárová, Jozef Dodulík, Patrik Šulc, David Stejskal, Zdeněk Švagera, František Všianský, Jan Václavík
Publikováno v:
Journal of Clinical Medicine. 11:7191
Secretoneurin (SN) is a 33 amino-acid evolutionary conserved neuropeptide from the chromogranin peptide family. SN’s main effects may be cardioprotective and are believed to be mediated through its inhibition of calmodulin-dependent kinase II (CaMK